Innovative Biosensors pockets $3.5M

Tiny start-up Innovative Biosensors has raised $3.5 million in first round venture financing. The College Park, Maryland-based company licensed its technology from MIT and is developing technology that can quickly detect pathogens. Executives at the upstart say that the technology will also be useful in drug discovery and rapid diagnosis. Harbert Venture Partners led the round. Other investors include New Markets Growth Fund and the Maryland Venture Fund.

- read this press release for more on the company

ALSO: Ophthalmic company InSite Vision has raised $9 million in private financing. Story

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.